ArticleAmerican journal of hematology2021

A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.

Hans C Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.